Selected article for: "dose model and major dose"

Author: Stäger, Simona; Rafati, Sima
Title: CD8(+) T Cells in Leishmania Infections: Friends or Foes?
  • Document date: 2012_1_24
  • ID: uofygmeu_10
    Snippet: Although the role of CD8 + T cells-derived IFN-γ has been clarified, little is known about the involvement of cytotoxic CD8 + T cells in cutaneous leishmaniasis. In a low-dose model of L. major infection, CD8 + T cell responses were shown not only to be protective, but also to mediate pathology (Belkaid et al., 2002) . Hence, it is possible that CTLs may be involved in the ulceration of skin lesions through tissue disruption. This suggests that .....
    Document: Although the role of CD8 + T cells-derived IFN-γ has been clarified, little is known about the involvement of cytotoxic CD8 + T cells in cutaneous leishmaniasis. In a low-dose model of L. major infection, CD8 + T cell responses were shown not only to be protective, but also to mediate pathology (Belkaid et al., 2002) . Hence, it is possible that CTLs may be involved in the ulceration of skin lesions through tissue disruption. This suggests that perhaps two types of CD8 + T cell effectors are generated during L. major infection: antigen-specific CD8 + T cells that produce IFN-γ but lack cytotoxic activity; and CTLs that are potent killers but produce little to no IFN-γ and promote pathology.

    Search related documents:
    Co phrase search for related documents
    • cell effector and low dose: 1
    • cell effector and major infection: 1
    • cell response and cutaneous leishmaniasis: 1
    • cell response and cytotoxic activity: 1, 2, 3, 4, 5, 6
    • cell response and low dose: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14
    • cell response and low dose model: 1, 2
    • cell response and major infection: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16
    • cell response and potent killer: 1
    • cutaneous leishmaniasis and low dose: 1
    • cutaneous leishmaniasis and low dose model: 1
    • cutaneous leishmaniasis and major infection: 1, 2
    • cutaneous leishmaniasis and skin lesion: 1
    • cytotoxic activity and low dose: 1, 2, 3, 4
    • cytotoxic activity and low dose model: 1
    • cytotoxic activity and major infection: 1, 2, 3, 4
    • low dose and major infection: 1, 2, 3, 4, 5
    • low dose model and major infection: 1